missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human DDA1 (aa 82-102) Control Fragment Recombinant Protein
Description
Highest antigen sequence indentity to the following orthologs: Mouse (95%), Rat (95%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-65934 (PA5-65934. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Functions as a component of numerous distinct DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complexes which mediate the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed:17452440, PubMed:28437394, PubMed:28302793, PubMed:31686031, PubMed:31819272). In the DCX complexes, acts as a scaffolding subunit required to stabilize the complex (PubMed:31686031, PubMed:31819272). [UniProt]
Specifications
Specifications
| Accession Number | Q9BW61 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 79016 |
| Name | Human DDA1 (aa 82-102) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | 1500034J01Rik; 1700095J19Rik; C19orf58; cross-immune reaction antigen PCIA1; Dda1; DET1 and DDB1 associated 1; DET1- and DDB1-associated protein 1; PCIA1; PCIA-1; Placenta cross-immune reaction antigen 1; R74921 |
| Common Name | DDA1 |
| Show More |